Haemophilus influenzae
Antibiotic |
% Susceptible |
Antibiotic |
% Susceptible |
|
| Ampicillin | 66 |
Imipenem | + |
|
| Azithromycin | 95 |
Levofloxacin | + |
|
| Aztreonam | + |
Meropenem | + |
|
| Cefazolin | Moxifloxacin | +
|
||
| Cefepime | + |
Nitrofurantoin | &
|
|
| Ceftazidime | + |
Oxacillin/Naf | - |
|
| Ceftriaxone | 95 |
Penicillin | - |
|
| Cefuroxime | 67 |
Piperacillin | 77
|
|
| Ciprofloxacin | 97 |
Piperacillin/tazo | 98 |
|
| Clarithromycin | 100 |
Ticarcillin/Clav | + |
|
| Clindamycin | - |
Tobramycin | + |
|
| Doxycycline | 96 |
TMP/SMX | 76 |
|
| Erythromycin | +/- |
Unasyn/Aug | 94 |
|
| Gentamicin | + |
Vancomycin | - |
|
Comments:
Numeric data represent local susceptibility data.
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy 2007
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy 2007
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections
